Therapeutic Drug Monitoring of Antibiotics in Critically Ill Patients: Current Practice and Future Perspectives With a Focus on Clinical Outcome.

Koch, Birgit C P; Muller, Anouk E; Hunfeld, Nicole G M; de Winter, Brenda C M; Ewoldt, Tim M J; Abdulla, Alan; Endeman, Henrik

Koch, Birgit C P; Muller, Anouk E; Hunfeld, Nicole G M; de Winter, Brenda C M; Ewoldt, Tim M J; Abdulla, Alan; Endeman, Henrik.

Afiliação

Koch BCP; Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
Muller AE; Department of Medical Microbiology, Haaglanden Medical Center, The Hague, the Netherlands.
Hunfeld NGM; Department of Medical Microbiology & Infectious Diseases, Erasmus MC, University Medical Center Rotterdam, the Netherlands; and.
de Winter BCM; Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
Ewoldt TMJ; Department of Adult Intensive Care, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
Abdulla A; Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, the Netherlands.
Endeman H; Department of Hospital Pharmacy, Erasmus MC, University Medical Center Rotterdam, the Netherlands.

Ther Drug Monit ; 44(1): 11-18, 2022 02 01.

Article em En | MEDLINE | ID: mdl-34772892

Assuntos

Antibacterianos; Estado Terminal; Estado Terminal/terapia; Monitoramento de Medicamentos/métodos; Humanos; Vancomicina/farmacocinética; Vancomicina/uso terapêutico; beta-Lactamas/farmacocinética

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Estado Terminal / Antibacterianos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Ther Drug Monit Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google